Skip to content
TrialScanner

NCT03688906

AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test

No phase registeredCompletedFRNMLead

Registry record

Lead sponsor
Freenome Holdings Inc.
Conditions
Colo-rectal Cancer; Cancer Colon; Cancer, Rectum; Neoplasms,Colorectal; Polyps
Primary completion
Nov 25, 2019Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03688906 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03688906: AI-EMERGE: Development and... | TrialScanner